Bristol Myers Squibb other operating income or expenses for the twelve months ending December 31, 2024 were $-0.893B, a 177.12% decline year-over-year.
Bristol Myers Squibb annual other operating income or expenses for 2024 were $-0.893B, a 177.12% decline from 2023.
Bristol Myers Squibb annual other operating income or expenses for 2023 were $1.158B, a 301.04% decline from 2022.
Bristol Myers Squibb annual other operating income or expenses for 2022 were $-0.576B, a 180% decline from 2021.
Bristol Myers Squibb Other Operating Income or Expenses 2010-2024 | BMY